BMJ Best Practice

参考文献

关键文献

Hayes EB, Sejvar JJ, Zaki SR, et al. Virology, pathology, and clinical manifestations of West Nile virus disease. Emerg Infect Dis. 2005;11:1174-1179.

Centers for Disease Control and Prevention. West Nile virus disease therapeutics: review of the literature for healthcare providers. February 2018 [internet publication].

参考文章

1.  Mostashari F, Bunning ML, Kitsutani PT, et al. Epidemic West Nile encephalitis, New York, 1999: results of a household-based seroepidemiological survey. Lancet. 2001;358:261-264.

2.  Pridjian G, Sirois PA, McRae S, et al. Prospective study of pregnancy and newborn outcomes in mothers with West nile illness during pregnancy. Birth Defects Res A Clin Mol Teratol. 2016;106:716-723.

3.  Campbell GL, Marfin AA, Lanciotti RS, et al. West Nile virus. Lancet Infect Dis. 2002;2:519-529.

4.  Petersen LR, Marfin AA. West Nile virus: a primer for the clinician. Ann Intern Med. 2002;137:173-179.

5.  Nash D, Mostashari F, Fine A, et al. The outbreak of West Nile virus infection in the New York City area in 1999. N Engl J Med. 2001;344:1807-1814.

6.  Centers for Disease Control and Prevention. Provisional surveillance summary of the West Nile virus epidemic - United States, January-November 2002. MMWR Morb Mortal Wkly Rep. 2002;51:1129-1133.

7.  Centers for Disease Control and Prevention. Preliminary maps & data for 2018. September 2018 [internet publication].

8.  European Centre for Disease Prevention and Control. Epidemiological update: West Nile virus transmission season in Europe, 2017. February 2018 [internet publication].

9.  Hayes EB, Komar N, Nasci RS, et al. Epidemiology and transmission dynamics of West Nile virus disease. Emerg Infect Dis. 2005;11:1167-1173.

10.  Beasley DW, Davis CT, Whiteman M, et al. Molecular determinants of virulence of West Nile virus in North America. Arch Virol Suppl. 2004;(18):35-41.

11.  Groves JA, Shafi H, Nomura JH, et al. A probable case of West Nile virus transfusion transmission. Transfusion. 2017 Mar;57(3pt2):850-856. 

12.  Centers for Disease Control and Prevention. Laboratory-acquired West Nile virus infections - United States, 2002. MMWR Morb Mortal Wkly Rep. 2002;51:1133-1135.

13.  Iwamoto M, Jernigan DB, Guasch A, et al. Transmission of West Nile virus from an organ donor to four transplant recipients. N Engl J Med. 2003;348:2196-2203.

14.  Biggerstaff BJ, Petersen LR. Estimated risk of West Nile virus transmission through blood transfusion in the United States, 2002. Transfusion. 2003;43:1007-1017.

15.  Centers for Disease Control and Prevention. Intrauterine West Nile virus infection - New York, 2002. MMWR Morb Mortal Wkly Rep. 2002;51:1135-1136.

16.  Centers for Disease Control and Prevention. Possible West Nile virus transmission to an infant through breast-feeding - Michigan, 2002. MMWR Morb Mortal Wkly Rep. 2002;51:877-878.

17.  Hayes EB, Sejvar JJ, Zaki SR, et al. Virology, pathology, and clinical manifestations of West Nile virus disease. Emerg Infect Dis. 2005;11:1174-1179.

18.  Sampson BA, Ambrosi C, Charlot A, et al. The pathology of human West Nile Virus infection. Hum Pathol. 2000;31:527-531.

19.  Shieh WJ, Guarner J, Layton M, et al. The role of pathology in an investigation of an outbreak of West Nile encephalitis in New York, 1999. Emerg Infect Dis. 2000;6:370-372.

20.  Kumar D, Prasad GV, Zaltzman J, et al. Community-acquired West Nile virus infection in solid-organ transplant recipients. Transplantation. 2004;77:399-402.

21.  Centers for Disease Control and Prevention (CDC). West Nile virus infections in organ transplant recipients - New York and Pennsylvania, August-September, 2005. MMWR Morb Mortal Wkly Rep. 2005;54:1021-1023.

22.  Lee BY, Biggerstaff BJ. Screening the United States blood supply for West Nile Virus: a question of blood, dollars, and sense. PLoS Med. 2006;3:e99.

23.  Korves CT, Goldie SJ, Murray MB. Cost-effectiveness of alternative blood-screening strategies for West Nile Virus in the United States. PLoS Med. 2006;3:e21.

24.  Joint United Kingdom (UK) Blood Transfusion and Tissue Transplantation Services Professional Advisory Committee. JPAC Position Statement on West Nile Virus. August 2015 [internet publication].

25.  National Institutes of Health. NIH-funded vaccine for West Nile virus enters human clinical trials. July 2015 [internet publication].

26.  Pierce KK, Whitehead SS, Kirkpatrick BD, et al. A live attenuated chimeric West Nile virus vaccine, rWN/DEN4Δ30, is well tolerated and immunogenic in flavivirus-naive older adult volunteers. J Infect Dis. 2017 Jan 1;215(1):52-55.

27.  Chan CK, Limstrom SA, Tarasewicz DG, et al. Ocular features of West Nile virus infection in North America: a study of 14 eyes. Ophthalmology. 2006;113:1539-1546.

28.  Sejvar JJ, Bode AV, Marfin AA, et al. West Nile virus-associated flaccid paralysis. Emerg Infect Dis. 2005;11:1021-1027.

29.  Marfin AA, Gubler DJ. West Nile encephalitis: an emerging disease in the United States. Clin Infect Dis. 2001;33:1713-1719.

30.  Martin DA, Muth DA, Brown T, et al. Standardization of immunoglobulin M capture enzyme-linked immunosorbent assays for routine diagnosis of arboviral infections. J Clin Microbiol. 2000;38:1823-1826.

31.  Roehrig JT, Nash D, Maldin B, et al. Persistence of virus-reactive serum immunoglobulin M antibody in confirmed West Nile virus encephalitis cases. Emerg Infect Dis. 2003;9:376-379.

32.  Kapoor H, Signs K, Somsel P, et al. Persistence of West Nile Virus (WNV) IgM antibodies in cerebrospinal fluid from patients with CNS disease. J Clin Virol. 2004;31:289-291.

33.  Lustig Y, Mannasse B, Koren R, et al. Superiority of West Nile virus RNA detection in whole blood for diagnosis of acute infection. J Clin Microbiol. 2016;54:2294-2297.

34.  Lanciotti RS, Kerst AJ, Nasci RS, et al. Rapid detection of West Nile virus from human clinical specimens, field-collected mosquitoes, and avian samples by a TaqMan reverse transcriptase-PCR assay. J Clin Microbiol. 2000;38:4066-4071.

35.  Sejvar JJ, Haddad MB, Tierney BC, et al. Neurologic manifestations and outcome of West Nile virus infection. JAMA. 2003;290:511-515. Erratum in: JAMA. 2003;290:1318.

36.  Watson JT, Pertel PE, Jones RC, et al. Clinical characteristics and functional outcomes of West Nile Fever. Ann Intern Med. 2004;141:360-365.

37.  Hayes EB, Gubler DJ. West Nile virus: epidemiology and clinical features of an emerging epidemic in the United States. Ann Rev Med. 2006;57:181-194.

38.  Sejvar JJ, Leis AA, Stokic DS, et al. Acute flaccid paralysis and West Nile virus infection. Emerg Infect Dis. 2003;9:788-793.

39.  Li J, Loeb JA, Shy ME, et al. Asymmetric flaccid paralysis: a neuromuscular presentation of West Nile virus infection. Ann Neurol. 2003;53:703-710.

40.  Ferguson DD, Gershman K, LeBailly A, et al. Characteristics of the rash associated with West Nile virus fever. Clin Infect Dis. 2005;41:1204-1207.

41.  Georges AJ, Lesbordes JL, Georges-Courbot MC, et al. Fatal hepatitis from West Nile virus. Ann Inst Pasteur Virol. 1987;138:237-244.

42.  Perelman A, Stern J. Acute pancreatitis in West Nile fever. Am J Trop Med Hyg. 1974;23:1150-1152.

43.  Carson PJ, Konewko P, Wold KS, et al. Long-term clinical and neuropsychological outcomes of West Nile virus infection. Clin Infect Dis. 2006;43:723-730.

44.  Leis AA, Stokic DS. Neuromuscular manifestations of human West Nile virus infection. Curr Treat Options Neurol. 2005;7:15-22.

45.  Jeha LE, Sila CA, Lederman RJ. West Nile virus infection: a new acute paralytic illness. Neurology. 2003;61:55-59.

46.  Ahmed S, Libman R, Wesson K, et al. Guillain-Barre syndrome: an unusual presentation of West Nile virus infection. Neurology. 2000;55:144-146.

47.  Rawal A, Gavin PJ, Sturgis CD. Cerebrospinal fluid cytology in seasonal epidemic West Nile virus meningo-encephalitis. Diagn Cytopathol. 2006;34:127-129.

48.  Tyler KL, Pape J, Goody RJ, et al. CSF findings in 250 patients with serologically confirmed West Nile virus meningitis and encephalitis. Neurology. 2006;66:361-365.

49.  Aksamit AJ. Herpes simplex encephalitis in adults and older children. Curr Treat Options Neurol. 2005;7:145-150.

50.  Cinque P, Cleator GM, Weber T, et al. The role of laboratory investigation in the diagnosis and management of patients with suspected herpes simplex encephalitis: a consensus report. The EU Concerted Action on Virus Meningitis and Encephalitis. J Neurol Neurosurg Psychiatry. 1996;61:339-345.

51.  Luby JP. Infections of the central nervous system. Am J Med Sci. 1992;304:379-391.

52.  Tsai TF. Arboviral infections in the United States. Infect Dis Clin North Am. 1991;5:73-102.

53.  Fitch MT, van de Beek D. Emergency diagnosis and treatment of adult meningitis. Lancet Infect Dis. 2007;7:191-200.

54.  Bicanic T, Harrison TS. Cryptococcal meningitis. Br Med Bull. 2005 Apr 18;72:99-118.

55.  Bhigjee AI, Padayachee R, Paruk H, et al. Diagnosis of tuberculous meningitis: clinical and laboratory parameters. Int J Infect Dis. 2007;11:348-354.

56.  Sejvar JJ, Marfin AA. Manifestations of West Nile neuroinvasive disease. Rev Med Virol. 2006;16:209-224.

57.  Wilske B, Fingerle V, Schulte-Spechtel U. Microbiological and serological diagnosis of Lyme borreliosis. FEMS Immunol Med Microbiol. 2007;49:13-21.

58.  Pachner AR, Steiner I. Lyme neuroborreliosis: infection, immunity, and inflammation. Lancet Neurol. 2007;6:544-552.

59.  Helmick CG, Bernard KW, D'Angelo LJ. Rocky Mountain spotted fever: clinical, laboratory, and epidemiological features of 262 cases. J Infect Dis. 1984;150:480-488.

60.  Chapman AS, Bakken JS, Folk SM, et al. Diagnosis and management of tickborne rickettsial diseases: Rocky Mountain spotted fever, ehrlichioses, and anaplasmosis - United States: a practical guide for physicians and other health-care and public health professionals. MMWR Recomm Rep. 2006;55:1-27.

61.  Cunha BA. The atypical pneumonias: clinical diagnosis and importance. Clin Microbiol Infect. 2006 May;12 Suppl 3:12-24.

62.  Tatter SB. Neurosurgical management of brain tumors. Neuroimaging Clin N Am. 1999;9:779-799.

63.  Kastrup O, Wanke I, Maschke M. Neuroimaging of infections. NeuroRx. 2005;2:324-332.

64.  Castillo PR, Miller DA, Meschia JF. Choice of neuroimaging in perioperative acute stroke management. Neurol Clin. 2006;24:807-820.

65.  Centers for Disease Control and Prevention. Arboviral diseases, neuroinvasive and non-neuroinvasive 2015 case definition. 2015 [internet publication].

66.  Hayes EB. West Nile virus disease in children. Pediatric Infect Dis J. 2006;25:1065-1066.

67.  Rimon A, Straussberg R, Amir J. West Nile encephalitis mimicking herpes encephalitis. Pediatr Neurol. 2006;35:62-64.

68.  Centers for Disease Control and Prevention. West Nile virus disease therapeutics: review of the literature for healthcare providers. February 2018 [internet publication].

69.  Chowers MY, Lang R, Nassar F, et al. Clinical characteristics of the West Nile fever outbreak, Israel, 2000. Emerg Infect Dis. 2001;7:675-678.

70.  Pepperell C, Rau N, Krajden S, et al. West Nile virus infection in 2002: morbidity and mortality among patients admitted to hospital in southcentral Ontario. CMAJ. 2003;168:1399-1405.

71.  Hart J Jr, Tillman G, Kraut MA, et al. West Nile virus neuroinvasive disease: neurological manifestations and prospective longitudinal outcomes. BMC Infect Dis. 2014 May 9;14:248.

72.  Petersen LR, Marfin AA, Gubler DJ. West Nile virus. JAMA. 2003;290:524-528.

73.  Gelfand MS. West Nile virus infection. What you need to know about this emerging threat. Postgrad Med. 2003;114:31-38.

74.  Bosanko CM, Gilroy J, Wang AM, et al. West Nile virus encephalitis involving the substantia nigra: neuroimaging and pathologic findings with literature review. Arch Neurol. 2003;60:1448-1452.

75.  Johnson RT, Cornblath DR. Poliomyelitis and flaviviruses. Ann Neurol. 2003;53:691-692.

76.  Zaltzman R, Klein C, Gordon CR. Opsoclonus myoclonus ataxia associated with West Nile virus infection: A dramatic presentation with benign prognosis? J Neurol Sci. 2017;376:38-41.

77.  Samaan Z, McDermid Vaz S, et al. Neuropsychological Impact of West Nile virus infection: an extensive neuropsychiatric assessment of 49 cases in Canada. PLoS One. 2016;11:e0158364.

使用此内容应接受我们的免责声明